Related Experiment Video
Updated: Feb 14, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
JTC-801 exerts anti-proliferative effects in human osteosarcoma cells by inducing apoptosis
Chang-Jun Zheng1, Li-Li Yang2, Jun Liu3
1a Department of Orthopaedics , The 2nd Hospital of Jilin University , Changchun , PR China.
Background:
The research of G protein-coupled receptors (GPCRs) is a promising strategy for drug discovery. In cancer therapy, there is a need to discover novel agents that can inhibit proliferation and induce apoptosis in cancer cells. JTC-801 is a novel GPCR antagonist with the function of reversing pain and anxiety symptoms. This study aims to investigate the antitumor effects of JTC-801 on human osteosarcoma cells (U2OS) and elucidate the underlying mechanism.
Materials And Methods:
The Cell Counting Kit-8 assay was used to detect the viability of U2OS cells treated with JTC-801 in vitro. The cell apoptosis was evaluated using a flow cytometry assay with Annexin V-FITC/PI double staining. The inhibitory effect of JTC-801 on invasion and migration of U2OS cells were determined by the Transwell assays. Western blot assay was performed to measure the levels of proteins related to cell apoptosis and its mechanism.
Results:
The JTC-801 significantly decreased the viability of U2OS cells (p < .05) as a result of its anti-proliferative effect through induction of apoptosis associated with activation of BAX, Caspase-3 and down-regulating BCL-2 expression. The invasive and migratory cells were obviously reduced after JTC-801 treatment (p < .05). Further, the phosphorylated AKT, mTOR and active p70 S6 protein kinase in the PI3K/AKT signaling pathway were obviously lessened in the JTC-801 treated U2OS group (p < .05).
Conclusions:
JTC-801 may exert osteosarcoma cell growth inhibition by promoting cell apoptosis, through PI3K/AKT signaling pathway participation.
Insights
JTC-801, a G protein-coupled receptor (GPCR) antagonist, inhibits osteosarcoma cell growth by inducing apoptosis and reducing cell invasion. It also impacts the PI3K/AKT signaling pathway, offering potential for cancer therapy.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- G protein-coupled receptors (GPCRs) are key targets for drug discovery.
- Novel agents are needed to inhibit cancer cell proliferation and induce apoptosis.
- JTC-801 is a novel GPCR antagonist with potential antitumor effects.
Purpose of the Study:
- Investigate the antitumor effects of JTC-801 on human osteosarcoma cells (U2OS).
- Elucidate the underlying mechanisms of JTC-801's action in osteosarcoma.
Main Methods:
- Cell Counting Kit-8 assay for cell viability.
- Flow cytometry with Annexin V-FITC/PI for apoptosis evaluation.
- Transwell assays for invasion and migration.
- Western blot for protein level analysis.
Main Results:
- JTC-801 significantly decreased U2OS cell viability and induced apoptosis by activating BAX and Caspase-3, while down-regulating BCL-2.
- JTC-801 treatment reduced cell invasion and migration.
- JTC-801 inhibited the PI3K/AKT signaling pathway by reducing phosphorylated AKT, mTOR, and active p70 S6 kinase.
Conclusions:
- JTC-801 exhibits antitumor effects against osteosarcoma cells.
- JTC-801 promotes apoptosis and inhibits proliferation and metastasis.
- The PI3K/AKT signaling pathway is involved in JTC-801's mechanism of action.
Related Concept Videos
Proliferative Phase
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
Apoptosis
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Biological Effects of Radiation
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...

